Enliven Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
Enliven Therapeutics (Nasdaq: ELVN), a clinical-stage biopharmaceutical company specializing in small molecule therapeutics discovery and development, has announced its upcoming participation in the TD Cowen 45th Annual Health Care Conference. The company's management will engage in a fireside chat scheduled for Tuesday, March 4, 2025, at 10:30 a.m. ET.
The event will be accessible through a live webcast on the company's investor relations website at ir.enliventherapeutics.com. Interested parties who cannot attend the live session can access the archived recording, which will remain available for 90 days after the event's conclusion.
Enliven Therapeutics (Nasdaq: ELVN), una società biofarmaceutica in fase clinica specializzata nella scoperta e nello sviluppo di terapie a piccole molecole, ha annunciato la sua prossima partecipazione alla 45ª Conferenza Annuale sulla Salute di TD Cowen. La direzione dell'azienda parteciperà a una conversazione informale programmata per martedì 4 marzo 2025, alle 10:30 ET.
L'evento sarà accessibile tramite una diretta web sul sito delle relazioni con gli investitori dell'azienda all'indirizzo ir.enliventherapeutics.com. Le parti interessate che non possono partecipare alla sessione dal vivo possono accedere alla registrazione archiviata, che rimarrà disponibile per 90 giorni dopo la conclusione dell'evento.
Enliven Therapeutics (Nasdaq: ELVN), una empresa biofarmacéutica en etapa clínica especializada en el descubrimiento y desarrollo de terapias de pequeñas moléculas, ha anunciado su próxima participación en la 45ª Conferencia Anual de Salud de TD Cowen. La dirección de la empresa participará en una charla informal programada para martes, 4 de marzo de 2025, a las 10:30 a.m. ET.
El evento será accesible a través de una transmisión en vivo en el sitio web de relaciones con los inversores de la empresa en ir.enliventherapeutics.com. Las partes interesadas que no puedan asistir a la sesión en vivo pueden acceder a la grabación archivada, que estará disponible durante 90 días después de la conclusión del evento.
Enliven Therapeutics (Nasdaq: ELVN)는 소분자 치료제 발견 및 개발을 전문으로 하는 임상 단계의 생명공학 회사로, TD Cowen 제45회 연례 건강 관리 회의에 참여할 예정이라고 발표했습니다. 회사 경영진은 2025년 3월 4일 화요일 오전 10시 30분 ET에 예정된 대화에 참여할 것입니다.
이 행사는 회사의 투자자 관계 웹사이트 ir.enliventherapeutics.com에서 실시간 웹캐스트를 통해 접근할 수 있습니다. 라이브 세션에 참석할 수 없는 이해관계자는 이벤트 종료 후 90일 동안 제공되는 아카이브 녹화에 접근할 수 있습니다.
Enliven Therapeutics (Nasdaq: ELVN), une entreprise biopharmaceutique en phase clinique spécialisée dans la découverte et le développement de thérapies à petites molécules, a annoncé sa prochaine participation à la 45e Conférence Annuelle de Santé de TD Cowen. La direction de l'entreprise participera à une discussion informelle prévue pour mardi 4 mars 2025, à 10h30 ET.
L'événement sera accessible via un webinaire en direct sur le site Web des relations investisseurs de l'entreprise à l'adresse ir.enliventherapeutics.com. Les parties intéressées qui ne peuvent pas assister à la session en direct peuvent accéder à l'enregistrement archivé, qui restera disponible pendant 90 jours après la fin de l'événement.
Enliven Therapeutics (Nasdaq: ELVN), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Entdeckung und Entwicklung von kleinen Molekülen spezialisiert hat, hat seine bevorstehende Teilnahme an der 45. jährlichen Gesundheitskonferenz von TD Cowen angekündigt. Das Management des Unternehmens wird an einem informellen Gespräch teilnehmen, das für Dienstag, den 4. März 2025, um 10:30 Uhr ET geplant ist.
Die Veranstaltung wird über einen Live-Stream auf der Investor-Relations-Website des Unternehmens unter ir.enliventherapeutics.com zugänglich sein. Interessierte Parteien, die nicht an der Live-Sitzung teilnehmen können, haben die Möglichkeit, auf die archivierte Aufnahme zuzugreifen, die 90 Tage nach Abschluss der Veranstaltung verfügbar bleibt.
- None.
- None.
The fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at https://ir.enliventherapeutics.com/. The webcast will be archived for a period of 90 days following the conclusion of the live event.
About Enliven Therapeutics
Enliven is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics to help people not only live longer, but live better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall well-being. Enliven's discovery process combines deep insights in clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies. Enliven is based in
View original content to download multimedia:https://www.prnewswire.com/news-releases/enliven-therapeutics-to-present-at-the-td-cowen-45th-annual-health-care-conference-302384762.html
SOURCE Enliven Therapeutics, Inc.
FAQ
When is Enliven Therapeutics (ELVN) presenting at the TD Cowen Healthcare Conference 2025?
How can investors watch Enliven Therapeutics' (ELVN) TD Cowen conference presentation?
How long will Enliven Therapeutics' (ELVN) TD Cowen conference presentation be available for replay?
What type of presentation will Enliven Therapeutics (ELVN) give at the TD Cowen conference?
